Nephrol Dial Transplant (2004) 19: 421-426
© ERA–EDTA 2004; all rights reserved
Original Article
Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study
1Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science and 2Neurogenetics Unit, Department of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Correspondence and offprint requests to: Peter Stenvinkel, MD, PhD, Division of Renal Medicine, K56, Huddinge University Hospital, 141 86 Stockholm, Sweden. Email: peter.stenvinkel{at}klinvet.ki.se
Background. Ghrelin is a newly detected orexigenic gastric hormone that stimulates food intake. Increased levels of ghrelin are often found in disease states associated with wasting. Wasting is a common phenomenon in end-stage renal disease (ESRD) patients in whom elevated ghrelin levels have been reported. However, no data are available on the relationship between body composition and plasma ghrelin levels in this patient group.
Methods. The study population consisted of 108 (71 males) ESRD patients aged 53±12 years. Body composition, nutritional status (subjective global assessment), estimated protein intake (nPNA), plasma ghrelin, plasma insulin and serum leptin were evaluated close to the start of dialysis treatment. Twelve healthy subjects (nine males, 44±6 years) served as the control group. A longitudinal evaluation of changes in plasma ghrelin and body composition was performed in 52 of the patients after 12 months of dialysis treatment.
Results. Markedly elevated plasma ghrelin levels (843±485 vs 443±302 pg/ml; P<0.01) were observed in ESRD patients compared with controls. Basal plasma ghrelin levels correlated significantly with plasma insulin (R = –0.32; P<0.05), body mass index (R = –0.24; P<0.05), log serum leptin levels (R = –0.23; P<0.05) and truncal fat mass (R = –0.25; P<0.05). The longitudinal analysis of body composition demonstrated that whereas fat mass increased (23.7±8.6 to 25.3±9.9kg; P<0.05) and plasma ghrelin levels decreased (855±429 to 693±408 pg/ml; P<0.05) significantly in peritoneal dialysis patients, no significant changes in either body composition or plasma ghrelin levels were found in patients treated by haemodialysis.
Conclusion. Markedly elevated plasma ghrelin levels are found in advanced renal failure and correlate with fat mass, plasma insulin and serum leptin levels. Changes in plasma ghrelin during 12 months of peritoneal dialysis treatment are associated with changes in body composition.
Keywords: body composition; end-stage renal disease; ghrelin; insulin; leptin; peritoneal dialysis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. K. Arbeiter, R. Buscher, S. Petersenn, B. P. Hauffa, K. Mann, and P. F. Hoyer Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation Nephrol. Dial. Transplant., February 1, 2009; 24(2): 643 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. DeBoer, X. Zhu, P. R. Levasseur, A. Inui, Z. Hu, G. Han, W. E. Mitch, J. E. Taylor, H. A. Halem, J. Z. Dong, et al. Ghrelin Treatment of Chronic Kidney Disease: Improvements in Lean Body Mass and Cytokine Profile Endocrinology, February 1, 2008; 149(2): 827 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Molfino, A. Laviano, F. R. Fanelli, M. Muscaritoli, and M. G. Chiappini Is des-acyl ghrelin contributing to uremic anorexia? Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1550 - 1551. [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Mak and W. Cheung ADIPOKINES AND GUT HORMONES IN END-STAGE RENAL DISEASE Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S298 - S302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wynne, K. Giannitsopoulou, C. J. Small, M. Patterson, G. Frost, M. A. Ghatei, E. A. Brown, S. R. Bloom, and P. Choi Subcutaneous Ghrelin Enhances Acute Food Intake in Malnourished Patients Who Receive Maintenance Peritoneal Dialysis: A Randomized, Placebo-Controlled Trial J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2111 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. St-Pierre, A. D. Karelis, K. Cianflone, F. Conus, D. Mignault, R. Rabasa-Lhoret, M. St-Onge, A. Tremblay-Lebeau, and E. T. Poehlman Relationship between Ghrelin and Energy Expenditure in Healthy Young Women J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5993 - 5997. [Abstract] [Full Text] [PDF]
|
|